Modelling synucleinopathies with human neurons derived from embryonic stem cells over-expressing α-Synuclein
dc.contributor.advisor
Kunath, Tilo
en
dc.contributor.advisor
Chandran, Siddharthan
en
dc.contributor.author
Yapom, Ratsuda
en
dc.contributor.sponsor
other
en
dc.date.accessioned
2017-07-06T13:14:36Z
dc.date.available
2017-07-06T13:14:36Z
dc.date.issued
2016-07-02
dc.description.abstract
α-Synuclein (αSyn) is a small intrinsically disordered protein that drives the progression of a
group of neurological disorders known of synucleinopathies, including Parkinson's disease,
dementia with Lewy bodies and multiple system atrophy. Increased expression of αSyn due
to gene duplication or triplication causes familial forms of these diseases, of which the
severity is positively correlated with the gene copy number. Despite extensive efforts using
various models, the precise mechanisms of αSyn toxicity in neurons have not been
elucidated. This could be partly due to biological differences between the models and
authentic human neurons.
In an attempt to model synucleinopathies with human neurons, I have established a
collection of transgenic human embryonic stem cell (hESC) lines over-expressing αSyn. I
first showed that elevated αSyn expression does not affect hESC proliferation and their
differentiation potential towards neurons. Then I identified transgenic hESC lines that
maintained high αSyn expression in differentiated neurons and compared the rate of reactive
oxygen species (ROS) production in high versus normal αSyn expressing cortical neuronal
cultures. I observed a significantly elevated level of ROS production in αSyn over-expressing
neurons in less mature neurons; however, there was no difference observed in
more mature neurons. The possible reasons that lead to this difference are discussed.
This is the first report of stable αSyn overexpressing hESC lines, which can provide an
unlimited source of human neurons for studying the mechanism underlying neuronal cell
death in synucleinopathies, which in turn could lead to the development of potential
therapeutics.
en
dc.identifier.uri
http://hdl.handle.net/1842/22812
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.subject
α-Synuclein
en
dc.subject
Parkinson's disease
en
dc.title
Modelling synucleinopathies with human neurons derived from embryonic stem cells over-expressing α-Synuclein
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
This item appears in the following Collection(s)

